Form 6-K GLAXOSMITHKLINE PLC For: May 22
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For period ending May 2015
GlaxoSmithKline plc
(Name of registrant)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
Form 20-F x Form 40-F
--
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes No x
--
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline Share Option Plan - Ordinary Shares
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
6,378,541
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
||||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
2,659,471
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
3,719,070
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline Share Option Plan - ADS
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
421,590
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
||||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
2,789,086
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
-2,367,496
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
Glaxo Wellcome UK Share Option Scheme
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
5,119,750
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
5,119,750
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
Glaxo Wellcome International Share Option Scheme
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
13,267,156
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
13,267,156
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
Glaxo Wellcome 1999 Share Option Plan
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
1,040,000
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
1,040,000
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
163,606
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
163,606
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
275,420
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
275,420
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
100,000
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
100,000
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline Savings Related Share Option Scheme
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
2,742,626
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
0
|
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
0
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
2,742,626
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 22 May 2015
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline plc Sharesave plan 2012
|
|||
Period of return:
|
From:
|
1 November 2014
|
To:
|
30 April 2015
|
Balance of unallotted securities under scheme(s) from previous return:
|
189,289
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
||||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
29,809
|
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
159,480
|
Name of contact:
|
Victoria Whyte
|
Telephone number of contact:
|
020 8047 5000
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
GlaxoSmithKline plc
(Registrant)
Date: May 22, 2015
By: VICTORIA WHYTE
----------------------
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Choice Properties Real Estate Investment Trust Reports Results for the Three Months Ended March 31, 2024
- Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
- ProPetro Increases Share Repurchase Authorization to $200 million
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!